SARS-CoV-2 vaccines have been linked to an immunomodulatory effect, with instances of autoimmune hepatitis and even with intrahepatic accumulation of activated CD8 T cells with SARS-CoV-2 specificity reported in one case (36–38). The gene discussed is CD8A; the disease is autoimmune hepatitis.